| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.00029 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |